-
1دورية أكاديمية
المؤلفون: McMurray, John J, Holman, Rury R, Haffner, Steven M, Bethel, M Angelyn, Holzhauer, Bjorn, Hua, Tsushung A, Belenkov, Yuri, Boolell, Mitradev, Buse, John B, Buckley, Brendan M, Chacra, Antonio R, Chiang, Fu*-Tien, Charbonnel, Bernard, Chow, Chun*-Chung, Davies, Melanie J, Deedwania, Prakash, Diem, Peter, Einhorn, Daniel, Fonseca, Vivian, Fulcher, Gregory R, Gaciong, Zbigniew, Gaztambide, Sonia, Giles, Thomas, Horton, Edward, Ilkova, Hasan, Jenssen, Trond, Kahn, Steven E, Krum, Henry, Laakso, Markku, Leiter, Lawrence A, Levitt, Naomi S, Mareev, Viacheslav, Martinez, Felipe, Masson, Chantal, Mazzone, Theodore, Meaney, Eduardo, Nesto, Richard, Pan, Changyu, Prager, Rudolf, Raptis, Sotirios A, Rutten, Guy E H M, Sandstroem, Herbert, Schaper, Frank, Scheen, André, Schmitz, Ole, Sinay, Isaac, Soska, Vladimir, Stender, Steen, Tamas, Gyula, Tognoni, Gianni, Tuomilehto, Jaako, Villamil, Alberto S, Vozar, Juraj, Califf, Robert M
المصدر: New England Journal of Medicine, 362 (16), 1477-90 (2010)
مصطلحات موضوعية: Angiotensin II Type 1 Receptor Blockers/adverse effects/therapeutic use, Blood Glucose/analysis/drug effects, Blood Pressure/drug effects, Body Weight/drug effects, Cardiovascular Diseases/epidemiology/mortality/prevention & control, Cyclohexanes/therapeutic use, Diabetes Mellitus, Type 2/epidemiology/prevention & control, Double-Blind Method, Drug Therapy, Combination, Exercise, Female, Follow-Up Studies, Glucose Intolerance/diet therapy/drug therapy/therapy, Humans, Hypoglycemic Agents/therapeutic use, Incidence, Male, Middle Aged, Phenylalanine/analogs & derivatives/therapeutic use, Proportional Hazards Models, Risk Factors, Tetrazoles/adverse effects/therapeutic use, Valine/adverse effects/analogs & derivatives/therapeutic use, Human health sciences, Endocrinology, metabolism & nutrition, Cardiovascular & respiratory systems, Pharmacy
العلاقة: http://www.nejm.orgTest; urn:issn:0028-4793; urn:issn:1533-4406; https://orbi.uliege.be/handle/2268/25987Test; info:hdl:2268/25987; https://orbi.uliege.be/bitstream/2268/25987Test/1/Effect%20of%20Valsartan%20on%20the%20Incidence.pdf; scopus-id:2-s2.0-77951453096; info:pmid:20228403
الإتاحة: https://doi.org/10.1056/NEJMoa1001121Test
https://orbi.uliege.be/handle/2268/25987Test
https://orbi.uliege.be/bitstream/2268/25987Test/1/Effect%20of%20Valsartan%20on%20the%20Incidence.pdf -
2
المؤلفون: McMurray, J. J., Young, J. B., Dunlap, M. E., Granger, C. B., Hainer, J., Michelson, E. L., Earle, S., Olofsson, B., Ostergren, J., Yusuf, S., Swedberg, Karl, 1944, Pfeffer, M. A.
المصدر: American heart journal. 151(5):985-91
مصطلحات موضوعية: Cardiac and Cardiovascular Systems, Kardiologi, Aged, Angiotensin II Type 1 Receptor Blockers/adverse effects/*therapeutic use, Angiotensin-Converting Enzyme Inhibitors/*administration &, dosage/therapeutic use, Benzimidazoles/adverse effects/*therapeutic use, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Heart Failure, Congestive/*drug therapy/*mortality/therapy, Hospitalization/statistics & numerical data, Humans, Male, Middle Aged, Proportional Hazards Models, Randomized Controlled Trials, Tetrazoles/adverse effects/*therapeutic use
الوصول الحر: https://gup.ub.gu.se/publication/50148Test